Date | Company Name | Action | Current Price | Price Target | Rating | Impact on Share Price |
---|
3/18/2024 | SHCO Soho House & Co Inc. | Reiterated Rating | $6.00 | | Outperform | Low |
3/13/2024 | MXCT MaxCyte | Reiterated Rating | $4.00 | | Outperform | Low |
3/13/2024 | CLBT Cellebrite DI | Upgrade | $12.00 | | Market Perform ➝ Outperform | Low |
3/12/2024 | ZVRA Zevra Therapeutics | Reiterated Rating | $6.00 | | Outperform | Low |
3/12/2024 | PAR PAR Technology | Reiterated Rating | $41.00 | | Outperform | Low |
3/12/2024 | ORCL Oracle | Upgrade | $128.00 | | Market Perform ➝ Outperform | Low |
3/8/2024 | PBPB Potbelly | Reiterated Rating | $12.00 | | Market Perform | Low |
3/8/2024 | ARCT Arcturus Therapeutics | Reiterated Rating | $33.00 | | Outperform | Low |
3/8/2024 | HCI HCI Group | Upgrade | $109.00 | | Market Perform ➝ Outperform | Low |
3/7/2024 | MDXH MDxHealth | Reiterated Rating | $3.00 | | Outperform | Low |
3/6/2024 | ALHC Alignment Healthcare | Reiterated Rating | $5.00 | | Outperform | Low |
3/6/2024 | MLNK MeridianLink | Reiterated Rating | $18.00 | | Outperform | Low |
3/6/2024 | CODI Compass Diversified | Reiterated Rating | $23.00 | | Outperform | Low |
3/5/2024 | NKTR Nektar Therapeutics | Reiterated Rating | $1.00 | | Market Perform | Low |
3/5/2024 | MXCT MaxCyte | Reiterated Rating | $4.00 | | Outperform | Low |
3/5/2024 | SMWB Similarweb | Reiterated Rating | $9.00 | | Outperform | Low |
3/5/2024 | AVAV AeroVironment | Reiterated Rating | $144.00 | | Outperform | Low |
3/4/2024 | REKR Rekor Systems | Initiated Coverage | $2.00 | | Outperform | Low |
3/1/2024 | STER Sterling Check | Downgrade | $16.00 | | Outperform ➝ Market Perform | Low |
2/29/2024 | ALKT Alkami Technology | Reiterated Rating | $23.00 | | Outperform | Low |
2/29/2024 | KFY Korn Ferry | Upgrade | $64.00 | | Market Perform ➝ Outperform | Low |
2/28/2024 | TWKS Thoughtworks | Reiterated Rating | $2.00 | | Outperform ➝ Market Perform | Low |
2/28/2024 | ZETA Zeta Global | Reiterated Rating | $11.00 | | Outperform | Low |
2/28/2024 | FLYW Flywire | Reiterated Rating | $26.00 | | Outperform | Low |
2/28/2024 | KVYO Klaviyo | Reiterated Rating | $25.00 | | Outperform | Low |
2/27/2024 | FGEN FibroGen | Reiterated Rating | $2.00 | | Market Perform | Low |
2/27/2024 | JANX Janux Therapeutics | Reiterated Rating | $39.00 | | Outperform | Low |
2/27/2024 | ANRO Alto Neuroscience | Initiated Coverage | $14.00 | | Outperform | Low |
2/27/2024 | CAVA CAVA Group | Reiterated Rating | $62.00 | | Outperform | Low |
2/27/2024 | KRYS Krystal Biotech | Reiterated Rating | $169.00 | | Outperform | Low |
2/26/2024 | MLTX MoonLake Immunotherapeutics | Reiterated Rating | $49.00 | $92.00 | Outperform | Low |
2/23/2024 | DVAX Dynavax Technologies | Reiterated Rating | $12.00 | | Outperform | Low |
2/23/2024 | VCYT Veracyte | Reiterated Rating | $22.00 | | Outperform | Low |
2/23/2024 | VKTX Viking Therapeutics | Reiterated Rating | $63.00 | | Outperform | Low |
2/23/2024 | CVNA Carvana | Upgrade | $81.00 | | Market Perform ➝ Outperform | Low |
2/23/2024 | SQ Block | Reiterated Rating | $81.00 | | Market Perform | Low |
2/22/2024 | BROS Dutch Bros | Reiterated Rating | $34.00 | | Outperform | Low |
2/22/2024 | EXAS Exact Sciences | Reiterated Rating | $59.00 | | Outperform | Low |
2/21/2024 | NEO NeoGenomics | Reiterated Rating | $15.00 | | Outperform | Low |
2/21/2024 | KROS Keros Therapeutics | Reiterated Rating | $64.00 | | Outperform | Low |
2/20/2024 | SPRY ARS Pharmaceuticals | Upgrade | $9.00 | | Market Perform ➝ Outperform | Low |
2/20/2024 | HSTM HealthStream | Reiterated Rating | $26.00 | | Outperform | Low |
2/16/2024 | KNTE Kinnate Biopharma | Downgrade | $3.00 | | Outperform ➝ Market Perform | Low |
2/16/2024 | APPN Appian | Reiterated Rating | $37.00 | | Outperform | Low |
2/16/2024 | DDOG Datadog | Reiterated Rating | $121.00 | | Outperform | Low |
2/15/2024 | SMWB Similarweb | Reiterated Rating | $9.00 | | Outperform | Low |
2/15/2024 | INGN Inogen | Upgrade | $7.00 | | Market Perform ➝ Outperform | Low |
2/15/2024 | IRDM Iridium Communications | Downgrade | $26.00 | | Outperform ➝ Market Perform | Low |
2/15/2024 | HUBS HubSpot | Reiterated Rating | $600.00 | | Outperform | Low |
2/14/2024 | BL BlackLine | Downgrade | $64.00 | | Outperform ➝ Market Perform | Low |
2/14/2024 | QDEL QuidelOrtho | Reiterated Rating | $49.00 | | Outperform ➝ Market Perform | Low |
2/12/2024 | CBAY CymaBay Therapeutics | Downgrade | $32.00 | | Outperform ➝ Market Perform | Low |
2/9/2024 | MSI Motorola Solutions | Reiterated Rating | $340.00 | | Outperform | Low |
2/8/2024 | NVST Envista | Downgrade | $21.00 | | Outperform ➝ Market Perform | Low |
2/8/2024 | PYPL PayPal | Reiterated Rating | $64.00 | | Outperform | Low |
2/8/2024 | WEX WEX | Reiterated Rating | $233.00 | | Outperform | Low |
2/8/2024 | FLT FLEETCOR Technologies | Reiterated Rating | $299.00 | | Outperform | Low |
2/7/2024 | WU Western Union | Reiterated Rating | $14.00 | | Market Perform | Low |
2/7/2024 | EHC Encompass Health | Reiterated Rating | $76.00 | | Outperform | Low |
2/7/2024 | JKHY Jack Henry & Associates | Reiterated Rating | $170.00 | | Outperform | Low |
2/6/2024 | SYM Symbotic | Reiterated Rating | $45.00 | | Market Perform | Low |
2/6/2024 | INCY Incyte | Reiterated Rating | $57.00 | | Outperform | Low |
2/6/2024 | VRTX Vertex Pharmaceuticals | Reiterated Rating | $411.00 | | Outperform | Low |
2/5/2024 | EVBG Everbridge | Downgrade | $35.00 | | Outperform ➝ Market Perform | Low |
2/5/2024 | ADUS Addus HomeCare | Reiterated Rating | $101.00 | | Outperform | Low |
2/2/2024 | LESL Leslie's | Reiterated Rating | $7.00 | | Market Perform | Low |
2/2/2024 | COUR Coursera | Reiterated Rating | $14.00 | | Outperform | Low |
2/2/2024 | HOLX Hologic | Reiterated Rating | $76.00 | | Outperform | Low |
2/2/2024 | TEAM Atlassian | Reiterated Rating | $197.00 | | Outperform | Low |
1/31/2024 | CHKP Check Point Software Technologies | Upgrade | $166.00 | | Market Perform ➝ Outperform | Low |
1/31/2024 | MA Mastercard | Reiterated Rating | $479.00 | | Outperform | Low |
1/29/2024 | AIR AAR | Initiated Coverage | $63.00 | | Outperform | Low |
1/29/2024 | ABBV AbbVie | Upgrade | $179.00 | | Market Perform ➝ Outperform | Low |
1/26/2024 | EXEL Exelixis | Reiterated Rating | $23.00 | | Outperform | Low |
1/26/2024 | V Visa | Reiterated Rating | $285.00 | | Outperform | Low |
1/23/2024 | MKTX MarketAxess | Reiterated Rating | $219.00 | | Outperform | Low |
1/22/2024 | COCO Vita Coco | Downgrade | $25.00 | | Outperform ➝ Market Perform | Low |
1/17/2024 | NTNX Nutanix | Upgrade | $65.00 | | Market Perform ➝ Outperform | Low |
1/10/2024 | BIIB Biogen | Reiterated Rating | $219.00 | | Outperform | Low |
1/9/2024 | BLUE bluebird bio | Reiterated Rating | $1.00 | | Market Perform | Low |
1/9/2024 | MDXH MDxHealth | Reiterated Rating | $3.00 | | Outperform | Low |
1/9/2024 | MXCT MaxCyte | Reiterated Rating | $4.00 | | Outperform | Low |
1/9/2024 | ACCD Accolade | Reiterated Rating | $10.00 | | Outperform | Low |
1/9/2024 | EVH Evolent Health | Reiterated Rating | $32.00 | | Outperform | Low |
1/9/2024 | U Unity Software | Reiterated Rating | $26.00 | | Outperform | Low |
1/8/2024 | BRNS Barinthus Biotherapeutics | Reiterated Rating | $2.00 | | Outperform | Low |
1/8/2024 | DTC Solo Brands | Downgrade | $2.00 | | Outperform ➝ Market Perform | Low |
1/8/2024 | EXEL Exelixis | Reiterated Rating | $23.00 | | Outperform | Low |
1/8/2024 | HOLX Hologic | Reiterated Rating | $76.00 | | Outperform | Low |
1/8/2024 | EXAS Exact Sciences | Reiterated Rating | $59.00 | | Outperform | Low |
1/8/2024 | MAN ManpowerGroup | Initiated Coverage | $74.00 | | Market Perform | Low |
1/8/2024 | BECN Beacon Roofing Supply | Upgrade | $88.00 | | Market Perform ➝ Outperform | Low |
1/8/2024 | ALNY Alnylam Pharmaceuticals | Reiterated Rating | $147.00 | | Outperform | Low |
1/5/2024 | FUSN Fusion Pharmaceuticals | Reiterated Rating | $11.00 | | Outperform | Low |
1/5/2024 | FTRE Fortrea | Initiated Coverage | $40.00 | | Market Perform | Low |
1/5/2024 | IDXX IDEXX Laboratories | Reiterated Rating | $530.00 | | Outperform | Low |
1/3/2024 | ENOV Enovis | Initiated Coverage | $59.00 | | Outperform | Low |
1/2/2024 | PATH UiPath | Initiated Coverage | $23.00 | | Outperform | Low |
12/26/2023 | RYZB RayzeBio | Downgrade | $62.00 | | Outperform ➝ Market Perform | N/A |
12/22/2023 | KRTX Karuna Therapeutics | Downgrade | $330.00 | | Outperform ➝ Market Perform | Low |